Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 272,867 | 267,299 | 274,352 | 336,837 | 307,976 |
| Cost of Goods | 51,383 | 52,518 | 50,715 | 57,014 | 57,651 |
| Gross Profit | 221,484 | 214,781 | 223,637 | 279,823 | 250,325 |
| Operating Expenses | 188,800 | 183,794 | 183,582 | 226,117 | 206,779 |
| Operating Income | 33,067 | 31,505 | 40,770 | 53,720 | 44,197 |
| Interest Expense | 32 | 18 | 18 | 16 | 5 |
| Other Income | 252 | 159 | -402 | 606 | 144 |
| Pre-tax Income | 33,287 | 31,646 | 40,350 | 54,310 | 44,336 |
| Income Tax | 10,818 | 11,326 | 13,020 | 16,076 | 13,715 |
| Net Income Continuous | 22,469 | 20,320 | 27,330 | 38,234 | 30,621 |
| Net Income | $22,469 | $20,320 | $27,330 | $38,234 | $30,621 |
| EPS Basic Total Ops | 1.16 | 1.05 | 1.37 | 1.89 | 1.47 |
| EPS Basic Continuous Ops | 1.16 | 1.06 | 1.37 | 1.89 | 1.47 |
| EPS Diluted Total Ops | 1.15 | 1.05 | 1.36 | 1.87 | 1.45 |
| EPS Diluted Continuous Ops | 1.15 | 1.05 | 1.36 | 1.87 | 1.45 |
| EBITDA(a) | $38,673 | $37,166 | $46,254 | $59,278 | $49,687 |